INFECTION PREVENTION
anti-re ux device helped reduce occlusions by 69 percent, while also lowering needle- less connector consumption by 1 percent. Overall, we estimate an annual savings of more than 20,000 by reducing occlusions and CIs, as well as the use of alteplase, heparin and other supplies. 2
Device maintenance and disinfection nother focus for hospitals and healthcare facilities is keeping medical supplies and equipment in working order, clean and steril- ied for use on patients. ven before COVID, todays infusion
pump market was already strained due to D recalls and warnings for hardware and software errors, cybersecurity gaps, and issues relating to more stringent cleaning practices, emphasied usan iemeier, M, , , Chief ursing Officer, Ivenix, Inc., orth ndover, M. The pandemic also has emphasied an impor- tant element of medical device products the materials in which the devices are made of matters. To prevent infection, devices that withstand frequent, harsh chemicals used to disinfect between patients are key. Devices with ingress protection and few crevices to trap contaminants are equally important to prevent transmission of infec- tious pathogens.
Alcavis 50 and ExSept Plus from Angelini Pharma
with a long history of use on catheters. The lcavis leach ipes are chlorine-based surface disinfectants in three dilutions for a variety of hard surfaces, including infusion pumps and poles. urther, the company provides cleaning
and sanitiing products for other items in healthcare environments, expresses Padovan. Over the past eight months, ngelini Pharma has seen a remarkable increased interest from customers requesting products that facilitate antisepsis and disinfection in their facilities, she continued. This includes products for catheters, skin, hands and sur- faces. dialysis facility relayed to us that the addition of the lcavis leach ipes to disinfect frequently touched surfaces, such as countertops, waiting room furniture, and doorknobs, has given their patients a sense of comfort while they are in the facility. The nurse stated that her patients are less con- cerned coming in for their treatments, seeing that staff have implemented this procedure with regularity.
Ivenix Large-Volume Infusion Pump Michele Padovan, Clinical urse pecial-
ist, ngelini Pharma, Inc., ockville, MD, addresses the importance of catheter disinfec- tion with dialysis treatment. Tunneled, central venous catheters are
meant for long-term use in the hemodialysis patient (months to years), making them high-risk implantable items in an immune- suppressed patient, Padovan stressed. It is critical that the catheter is accessed aseptically for dialysis and that the exit site is kept clean and dry. or some dialysis patients, this CVC will remain their sole access for treatment if they have exhausted all peripheral means for phlebotomy. lcavis 0 is a high-level disinfectant with a broad and rapid kill and xept Plus is an isotonic catheter exit site cleanser both products are safe and effective
Protecting patients and staff Rapid care Controlling the transmission of COVID-19 among patients, staff and visitors remains top of mind in medical settings. The cri- sis, however, has taken a maor toll on necessary medical and personal protec- tive equipment (PP) items, emphasies aroline Draper, , M, V-C, miths Medical, Minneapolis, M. Our healthcare customers are currently
struggling under the weight of extremely sick and contagious patients, Draper shared. They are overwhelmed and under fi nancial strain, making it more diffi cult to allocate resources to much needed supplies. The companys POD family of products offers up to 90 percent completion of therapy for medication delivery, diagnos- tics and blood sampling, resulting in more effi cient care 3
, notes Draper.
e have seen a lack of PP for healthcare workers during COVID-19, Draper said. To keep nurses safe and prevent spread, clinicians are leaning on products like our POD midlines and extended dwell catheters to decrease utiliation of PP, by helping achieve one-stick hospital-
Page 26 24 January 2021 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
iation, and less time spent in COVID-19 rooms. 3-4
The
POD midline catheters can be placed in patients upon admission to the hospital andor COVID- 19-specifi c units. This prac- tice has been implemented in facilities with the intent to decrease delays of care, improve patient outcomes,4
protect staff from unnecessary exposure with restarts1
and reduce PP usage.
Managing supplies and care Increased inventory needs s the COVID-19 global public health emergency carries on, so does the pressure on healthcare supply chain and critical care operations, observes Matthew utchings,VP lobal Marketing and Innovation, Infusion ystems, IC Medical, an Clemente, C. ospitals around the world have not only experienced unprecedented surges of criti- cally ill COVID-19 patients, but this uncer- tainty and variability in patient volumes have also put signifi cant stress on the healthcare supply network, utchings addressed. t the onset of the pandemic, a rapid increase in patient volumes, coupled with the stockpil- ing of essential infusion consumables, created back orders and supply shortages from PP to core infusion sets and infusion pumps. In contrast, the volumes of elective surgeries are still far below pre-pandemic levels, plac- ing additional fi nancial burdens on hospitals and healthcare facilities. The change in seasons and viruses, utch-
ings indicates, will heighten tension on healthcare systems, supply availability, and capacity for treatment. The fall and winter months are tradition-
ally very busy for healthcare suppliers, as hospitals and healthcare facilities stock up on essential supplies for treating seasonal u patients, he emphasied. s COVID-19 continues to draw much of the supply from
ICU Medical’s Human Connections IV pump
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58